PL1664109T3 - Oczyszczanie peptydów glukagonopodobnych - Google Patents

Oczyszczanie peptydów glukagonopodobnych

Info

Publication number
PL1664109T3
PL1664109T3 PL04739040T PL04739040T PL1664109T3 PL 1664109 T3 PL1664109 T3 PL 1664109T3 PL 04739040 T PL04739040 T PL 04739040T PL 04739040 T PL04739040 T PL 04739040T PL 1664109 T3 PL1664109 T3 PL 1664109T3
Authority
PL
Poland
Prior art keywords
glucagon
peptides
purification
purifying
peptide
Prior art date
Application number
PL04739040T
Other languages
English (en)
Inventor
Arne Staby
Camilla Kornbeck
Dorte Lunoe Dünweber
Hanne Christensen
Ole Schou
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34219530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1664109(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL1664109T3 publication Critical patent/PL1664109T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL04739040T 2003-08-21 2004-08-18 Oczyszczanie peptydów glukagonopodobnych PL1664109T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200301197 2003-08-21
US49788703P 2003-08-25 2003-08-25
PCT/DK2004/000543 WO2005019262A1 (en) 2003-08-21 2004-08-18 Purification of glucagon-like peptides
EP04739040A EP1664109B1 (en) 2003-08-21 2004-08-18 Purification of glucagon-like peptides

Publications (1)

Publication Number Publication Date
PL1664109T3 true PL1664109T3 (pl) 2010-01-29

Family

ID=34219530

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04739040T PL1664109T3 (pl) 2003-08-21 2004-08-18 Oczyszczanie peptydów glukagonopodobnych

Country Status (7)

Country Link
EP (1) EP1664109B1 (pl)
JP (2) JP2007526235A (pl)
AT (1) ATE437181T1 (pl)
DE (1) DE602004022177D1 (pl)
ES (1) ES2330335T3 (pl)
PL (1) PL1664109T3 (pl)
WO (1) WO2005019262A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921518B2 (en) 2005-12-23 2014-12-30 Novo Nordisk A/S Purification of proteins using preparative reverse phase chromatography (RPC)
RU2461564C2 (ru) * 2008-02-06 2012-09-20 Байокон Лимитид Способ очистки циклического или нециклического пептида
WO2010066734A1 (en) * 2008-12-08 2010-06-17 Novo Nordisk A/S Counter current purification of polypeptides
JP5992836B2 (ja) 2010-03-01 2016-09-14 ノヴォ ノルディスク アー／エス ペプチドを精製するための分取ｒｐ−ｈｐｌｃ法
US20110313131A1 (en) * 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
ES2623979T3 (es) 2013-03-21 2017-07-12 Sanofi-Aventis Deutschland Gmbh Síntesis de productos peptídicos que contienen hidantoína
ES2624961T3 (es) 2013-03-21 2017-07-18 Sanofi-Aventis Deutschland Gmbh Síntesis de productos de péptido que contienen imida cíclica
JP7011643B2 (ja) * 2016-03-23 2022-02-10 バッヘン・ホールディング・アクチエンゲゼルシャフト グルカゴン様ペプチド１類似体の精製
WO2018104561A1 (en) * 2016-12-09 2018-06-14 Zealand Pharma A/S Acylated glp-1/glp-2 dual agonists
CN110066332A (zh) * 2018-01-23 2019-07-30 齐鲁制药有限公司 一种胰高血糖素样肽的捕获方法
DK3517543T3 (da) 2018-01-30 2020-12-07 Bachem Ag Fremstilling af glucagonpeptider
EP3897570A1 (en) 2018-12-19 2021-10-27 KRKA, d.d., Novo mesto Pharmaceutical composition comprising glp-1 analogue
WO2021123228A1 (en) 2019-12-18 2021-06-24 Krka, D.D., Novo Mesto Pharmaceutical composition comprising glp-1 analogue
CN118271420A (zh) * 2024-03-08 2024-07-02 江苏汉邦科技股份有限公司 一种glp-1类似物的纯化方法
CN118812695B (zh) * 2024-09-20 2025-01-28 杭州信海医药科技有限公司 一种利司那肽的纯化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184201B1 (en) * 1995-04-14 2001-02-06 Nps Allelix Corp. Intestinotrophic glucagon-like peptide-2 analogs
EP1231219B1 (en) * 1996-04-12 2010-08-25 1149336 Ontario Inc. GLucagon-like peptide-2 analogs
ATE509028T1 (de) * 1999-03-15 2011-05-15 Novo Nordisk As Ionen-austausch-chromatographische trennung von glp-1 und verwandten peptiden
US7595172B2 (en) * 2001-07-24 2009-09-29 Novo Nordisk A/S Method for making acylated polypeptides

Also Published As

Publication number Publication date
DE602004022177D1 (de) 2009-09-03
ES2330335T3 (es) 2009-12-09
EP1664109A1 (en) 2006-06-07
JP2007526235A (ja) 2007-09-13
JP2014210783A (ja) 2014-11-13
ATE437181T1 (de) 2009-08-15
EP1664109B1 (en) 2009-07-22
WO2005019262A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
PL1664109T3 (pl) Oczyszczanie peptydów glukagonopodobnych
PL1664108T3 (pl) Rozdzielanie polipeptydów zawierających racemizowany aminokwas
PL2092064T3 (pl) Sposób oczyszczania RNA na skalę preparatywną za pomocą HPLC
DK1809663T3 (da) Fremgangsmåde til oprensning af FSH
DK1689777T3 (da) Fremgangsmåde til oprensning af il18-bindende protein
WO2003066662A3 (en) Protein purification
WO2004024866A3 (en) Protein purification
WO2003102132A3 (en) Non-affinity purification of proteins
DE602004006725D1 (de) Reinigung von Antikörpern durch Protein A und Ionenaustauschromatographie
IL187935A0 (en) Process for the purification of il-18 binding protein
IL205275A0 (en) Peptide sequence for purifying pertussis toxin
WO2005026323A3 (en) Stationary phases and a purification process using the stationary phases
DK1805211T3 (da) Oprensning af glycopeptider
SI1656455T1 (sl) Postopek za čiščenje rekombinantnih polipeptidov
GB0312426D0 (en) Purification means
ITMI20020549A0 (it) Modulatore criogenico per gascromatografia
NO20041563L (no) Rensemetode for polypeptid
WO2005015239A3 (en) Method for n-terminal labeling of proteins
AU2003266135A1 (en) Method of visualizing proteins bound to protein-binding membranes
TW200720288A (en) Method of peptide synthesis
EP1758540A4 (en) PURIFICATION OF INSULIN-LIKE MATERIAL BY REVERSE-PHASE CHROMATOGRAPHY
PL376745A1 (pl) Proces oczyszczania białek wiążących TNF przy użyciu IMAC
GB0305552D0 (en) Purification of peptides
AU2003900039A0 (en) Phage linked protease for the purification of phage presented recombinant protein
PL1664086T3 (pl) Chromatograficzne rozdzielanie polipeptydów o znaczeniu terapeutycznym